Implantable medical device with circulation delay measurement and therapy control

• US 7,315,759 B2
• Filed: 09/21/2004
• Issued: 01/01/2008
• Est. Priority Date: 05/07/2004
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Jovanovic, Marina, Mehta, Pooja, Erickson, Mark K., Cho, Yong K., Sowelam, Sameh, Markowitz, H. Toby, Giese, Chad T.
• Primary Examiner(s): Sykes; Angela D.
• Assistant Examiner(s): FILOSI, TERRI LYNN
• Application Number:
  US10/945,639
• Publication Number:
  US 20050251218A1
• Time in Patent Office: 1,197 Days
• Field of Search: 607/20, 607/17, 607/42, 607/6, 607/18, 607/22, 607/62, 600323-325, 600/529, 600/484, 128/204.23
• US Class Current: 607/18
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/36557 controlled by chemical substances in blood

Abstract

Oxygen saturation data is monitored during a predefined window to obtain a measurement of circulation delay. The measured circulation delay is used as a basis for determining therapies, including overdrive pacing. In some embodiments, circulation delay is used to identify patients that will benefit from overdrive pacing as a therapy for sleep disordered breathing.

Claims

1. An implantable medical device system comprising:

an implantable pulse generator;

a controller coupled with the implantable pulse generator and selectively providing pacing stimuli;

an oximeter;

a respiration sensor; and

a circulation delay module communicatively coupled with the controller, the oximeter, and the respiration sensor and providing a measurement of circulation delay which is a time from a resumption of respiraton sensed by the respiration sensor to a nadir of oxygen saluration sensed by the oximeter, wherein the controller receives the measurment of circulation delay and selectively provides pacing based upon the measurement of circulation delay.

2. The implantable medical device system of claim 1, further comprising a housing including the implantable pulse generator, the controller, the oximeter and the circulation delay module.

3. The implantable medical device system of claim 1, wherein the oximeter is externally positioned and communicatively coupled with the circulation delay module via telemetry.

4. The implantable medical device system of claim 1, wherein the respiration sensor senses a termination of an apnea that initiates an observation window for the oximeter.

5. The implantable medical device system of claim 4, wherein the oximeter senses a lowest oxygen saturation point during the window and communicates that point to the circulation delay module.

6. The implantable medical device system of claim 1, wherein the controller initiates overdrive pacing if the measurement of circulation delay exceeds a predetermined threshold.

7. An implantable medical device system comprising:

an implantable pulse generator;

a controller coupled with the implantable pulse generator and selectively providing pacing stimuli;

an oximeter;

an apnea sensor configured to sense an onset and termination of an apnea event; and

a circulation delay module communicatively coupled with the controller, the oximeter, and the apnea sensor and providing a measurement of circulation delay that is measured from either the onset of the apnea event as sensed by the apnea sensor to a perceived onset of the apnea event as sensed by the oximeter or the termination of the apnea event as sensed by the apnea sensor to a perceived termination of the apnea event as sensed by the oximeter, wherein the controller receives the measurement of circulation delay and selectively provides pacing based upon the measurement of circulation delay.

8. The implantable medical device system of claim 7, further comprising a housing including the implantable pulse generator, the controller, the oximeter and the circulation delay module.

9. The implantable medical device system of claim 7, wherein the oximeter is externally positioned and communicatively coupled with the circulation delay module via telemetry.

10. The implantable medical device system of claim 7, wherein the apnea sensor is a respiration sensor communicatively coupled with the circulation delay module.

11. The implantable medical device system of claim 10, wherein the respiration sensor senses a termination of an apnea that initiates an observation window for the oximeter.

12. The implantable medical device system of claim 11, wherein the oximeter senses a lowest oxygen saturation point during the window and communicates that point to the circulation delay module.

13. The implantable medical device system of claim 7 wherein the controller initiates overdrive pacing if the measurement of circulation delay exceeds a predetermined threshold.